Cite
MLA Citation
Frances Boyle et al.. “Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm.” Asia-Pacific journal of clinical oncology, vol. 14, n.d., pp. 3–11. http://access.bl.uk/ark:/81055/vdc_100070085169.0x00000c